Austin Aerts Sells 7,179 Shares of Sera Prognostics, Inc. (NASDAQ:SERA) Stock

Sera Prognostics, Inc. (NASDAQ:SERA) CFO Austin Aerts sold 7,179 shares of the firm’s stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $7.32, for a total transaction of $52,550.28. Following the sale, the chief financial officer now owns 291,486 shares of the company’s stock, valued at $2,133,677.52. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

Austin Aerts also recently made the following trade(s):

• On Tuesday, September 10th, Austin Aerts sold 5,056 shares of Sera Prognostics stock. The shares were sold at an average price of $7.57, for a total transaction of $38,273.92.

Sera Prognostics Trading Down 3.7 %

Sera Prognostics stock opened at $6.97 on Thursday. The business’s 50 day simple moving average is $7.40 and its 200 day simple moving average is $7.65. Sera Prognostics, Inc. has a 12 month low of $1.65 and a 12 month high of $12.35. The company has a market cap of $232.59 million, a price-to-earnings ratio of -7.04 and a beta of 1.04.

Sera Prognostics (NASDAQ:SERA) last announced its quarterly earnings data on Wednesday, November 6th. The company reported ($0.24) earnings per share for the quarter, missing the consensus estimate of ($0.22) by ($0.02). The company had revenue of $0.03 million during the quarter, compared to the consensus estimate of $0.09 million. During the same period in the prior year, the business posted ($0.23) earnings per share. As a group, equities research analysts forecast that Sera Prognostics, Inc. will post -0.96 earnings per share for the current fiscal year.

Institutional Trading of Sera Prognostics

A number of institutional investors have recently modified their holdings of SERA. RA Capital Management L.P. bought a new position in shares of Sera Prognostics in the first quarter valued at approximately $18,420,000. AWM Investment Company Inc. lifted its stake in Sera Prognostics by 56.0% in the 1st quarter. AWM Investment Company Inc. now owns 584,664 shares of the company’s stock worth $5,320,000 after purchasing an additional 209,762 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Sera Prognostics by 100.2% in the 2nd quarter. Bank of New York Mellon Corp now owns 150,708 shares of the company’s stock valued at $892,000 after purchasing an additional 75,441 shares during the period. Ballentine Partners LLC purchased a new position in shares of Sera Prognostics during the 2nd quarter valued at $294,000. Finally, Twelve Points Wealth Management LLC bought a new position in shares of Sera Prognostics in the second quarter worth $257,000. 54.64% of the stock is currently owned by hedge funds and other institutional investors.

About Sera Prognostics

Sera Prognostics, Inc, a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies.